Pfizer and Moderna both received FDA authorization for mRNA vaccines, and phase 3 data efficacy was sky high.
Read Next
Pfizer and Moderna both received FDA authorization for mRNA vaccines, and phase 3 data efficacy was sky high.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.